Regen BioPharma (Regen BioPharma) Days Sales Outstanding : 40.21 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma Days Sales Outstanding?

Regen BioPharma's average Accounts Receivable for the three months ended in Mar. 2024 was $0.03 Mil. Regen BioPharma's Revenue for the three months ended in Mar. 2024 was $0.06 Mil. Hence, Regen BioPharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 40.21.

The historical rank and industry rank for Regen BioPharma's Days Sales Outstanding or its related term are showing as below:

RGBP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 103.62 Med: 302.95 Max: 391.18
Current: 103.62

During the past 11 years, Regen BioPharma's highest Days Sales Outstanding was 391.18. The lowest was 103.62. And the median was 302.95.

RGBP's Days Sales Outstanding is ranked worse than
67.08% of 890 companies
in the Biotechnology industry
Industry Median: 71.92 vs RGBP: 103.62

Regen BioPharma's Days Sales Outstanding increased from Mar. 2023 (0.00) to Mar. 2024 (40.21).

Regen BioPharma Days Sales Outstanding Historical Data

The historical data trend for Regen BioPharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regen BioPharma Days Sales Outstanding Chart

Regen BioPharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Sales Outstanding

Get a 7-Day Free Trial

235.59

288.68

337.25

361.13

391.18

Regen BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															-	88.16	88.16	18.56	40.21

Competitive Comparison of Regen BioPharma's Days Sales Outstanding

For the Biotechnology subindustry, Regen BioPharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regen BioPharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's Days Sales Outstanding falls into.

Regen BioPharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Regen BioPharma's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

	Days Sales Outstanding (A: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (0.254	+	0)	/	1 )	/	0.237	*	365
=	0.254					/	0.237	*	365
=	391.18

Regen BioPharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.012	+	0.04)	/	2 )	/	0.059	*	365 / 4
=	0.026					/	0.059	*	365 / 4
=	40.21

Regen BioPharma (OTCPK:RGBP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Regen BioPharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Regen BioPharma (Regen BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RGBPP.PFD:USA

Address

4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942

Website

https://www.regenbiopharmainc.com

Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.